Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer.
Faria SL, Souhami L, Portelance L, Duclos M, Vuong T, Small D, Freeman CR.
Faria SL, et al. Among authors: small d.
Radiat Oncol. 2006 Nov 1;1:42. doi: 10.1186/1748-717X-1-42.
Radiat Oncol. 2006.
PMID: 17078878
Free PMC article.
This study reports our results on patients with medically inoperable, early stage, non-small cell lung cancer (NSCLC) treated with hypofractionation. MATERIALS AND METHODS: Stage T1-2N0 NSCLC patients were treated with hypofractionation alone, 52.5 Gy/15 fractions, in 3 we …
This study reports our results on patients with medically inoperable, early stage, non-small cell lung cancer (NSCLC) treated with hy …